CN101862342B - External medicament for treating dermatophytosis - Google Patents
External medicament for treating dermatophytosis Download PDFInfo
- Publication number
- CN101862342B CN101862342B CN2010101982413A CN201010198241A CN101862342B CN 101862342 B CN101862342 B CN 101862342B CN 2010101982413 A CN2010101982413 A CN 2010101982413A CN 201010198241 A CN201010198241 A CN 201010198241A CN 101862342 B CN101862342 B CN 101862342B
- Authority
- CN
- China
- Prior art keywords
- grams
- clotrimazole
- kitasamycin
- metronidazole
- mainly
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention relates to a medicament for treating dermatophytosis, which comprises the following raw materials: 20 to 25 grams of chlortrimeton, 25 to 30 grams of hexadecadrol, 5 to 8 grams of metronidazole, 10 to 12 grams of compound dexamethasone acetate, 10 to 15 grams of clotrimazole and 8 to 10 grams of crystallized kitasamycin. In the external medicament, the metronidazole and the crystallized kitasamycin mainly play a role in clearing heat and eliminating dampness; the compound dexamethasone acetate and the hexadecadrol mainly have the effect of detoxifying and relieving itching; and the chlortrimeton and the clotrimazole mainly prevent allergic symptoms from occurring. The medicaments play a role commonly to treat internally and externally, treat the dermatophytosis effectively and have the effects of clearing heat and eliminating dampness, detoxifying and relieving itching and invigorating the circulation of blood and promoting tissue regeneration.
Description
Affiliated technical field
The present invention relates to a kind of topical drug, especially a kind of external used medicine of multicomponent treatment beriberi.
Background technology
Beriberi is a kind of commonly encountered diseases, frequently-occurring disease, also has infectious characteristics simultaneously, and it is mainly due to damp invasion of lower energizer or occupy wetland for a long time and form.Generally can only reach outside antipruritic effect during present Drug therapy, can not fundamentally solve, thereby its therapeutic effect be not ideal enough.
Summary of the invention
The object of the present invention is to provide a kind of medicine of fundamentally curing beriberi of energy internal and external application.
Multiple medicines such as employing chlorphenamine of the present invention, dexamethasone, metronidazole, PIYANPING, clotrimazole, crystallization kitasamycin carry out mixing match and reach internal and external application, fundamentally cure the medicine of beriberi.
Raw material of the present invention is formed and weight ratio is: chlorphenamine 20～25, dexamethasone 25～30, metronidazole 5～8, PIYANPING 10～12, clotrimazole 10～15, crystallization kitasamycin 8～10.
Raw material of the present invention is formed and optimum weight ratio is: chlorphenamine 20, dexamethasone 30, metronidazole 5, PIYANPING 10, clotrimazole 10, crystallization kitasamycin 10.
In the present invention, metronidazole, crystallization kitasamycin mainly play the wet effectiveness of heat clearing away bath; PIYANPING, dexamethasone are mainly in order to the effect of detoxifying and relieving itching; Chlorphenamine, clotrimazole are mainly avoided the generation of allergic symptom.Above-mentioned all medicine combineds effect can reach internal and external application, treat beriberi effectively, reach the effect of heat clearing and damp drying, detoxifying and relieving itching, blood activating and promoting tissue regeneration.This medicine is through 10 years 1000 many cases patients of clinical trial, and effectively cure rate reaches 99.5%.There is not to find to have state of an illness phenomenon repeatedly.
Generally need the process through purifying, pulverizing during production product of the present invention, particularly raw-material buying will be checked on, and is processed into the medicine for external use that powder, unguentum are integrated according to conventional method then.
Specific implementation method:
Among following each embodiment, can be made as powder, unguentum, perhaps be made as unguentum according to following method according to conventional method:
Choose and meet the requirements or qualified chlorphenamine 20 grams, dexamethasone 30 grams, metronidazole 5 grams, PIYANPING 10 grams, clotrimazole 10 grams, crystallization kitasamycin 10 grams, with conventional pulverizer or grind to form powder; Powder is put into the bottle of packing into after PIYANPING, clotrimazole stir stir, i.e. graded external application is used.General 20 milliliters is a course of treatment, and can cure a course of treatment; Disease weight person suitably increases the time.
Metronidazole, crystallization kitasamycin mainly play the wet effectiveness of heat clearing away bath; PIYANPING, dexamethasone are mainly in order to the effect of detoxifying and relieving itching; Chlorphenamine, clotrimazole are mainly avoided the generation of allergic symptom.Above-mentioned all medicine combineds effect can reach internal and external application, treat beriberi effectively, reach the effect of heat clearing and damp drying, detoxifying and relieving itching, blood activating and promoting tissue regeneration.This medicine is through 10 years 1000 many cases patients of clinical trial, and effectively cure rate reaches 99.5%.There is not to find to have state of an illness phenomenon repeatedly.
Case:
Mr. Xu, people from Binzhou, Shandong passed by Liaocheng in 2005, saw this product, had the phychology of having a try in arms and bought a course of treatment, and the result does not use up, and beriberi is thoroughly effected a radical cure.
Yellow German army, the soldier of army went home to see one's folks in 2006, saw this product, and beriberi was more serious at that time, and prolonged exercise causes and control badly for a long time, and this product on probation is after 20 days, and beriberi is cured fully, and buys several again and take back army and use to the comrade-in-arms.
Wang Xiaohong, the woman, people from Kaifeng, during doing manual work in Shandong, owing to the work reason, beriberi, after upon somebody's introduction, select this product treatment thoroughly to effect a radical cure a course of treatment.
It should be noted that, although the present invention is described and illustrates with reference to the specific embodiment, but and do not mean that the present invention is limited to the embodiment of these descriptions, those skilled in the art can therefrom derive many different variants, and they all will be covered in the true spirit and scope of claim of the present invention.
Claims (3)
1. external used medicine for the treatment of beriberi, its raw material is formed and weight ratio is: chlorphenamine 20～25, dexamethasone 25～30, metronidazole 5～8, PIYANPING 10～12, clotrimazole 10～15, crystallization kitasamycin 8～10.
2. external used medicine for the treatment of beriberi, its raw material is formed and weight ratio is: chlorphenamine 20, dexamethasone 30, metronidazole 5, PIYANPING 10, clotrimazole 10, crystallization kitasamycin 10.
3. the processing method of the external used medicine of treatment beriberi according to claim 1 and 2, it is characterized in that: be ground into chlorphenamine, dexamethasone, metronidazole, crystallization kitasamycin Powdered, after putting into PIYANPING and clotrimazole and stirring, be made into the medicine body of paste.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010101982413A CN101862342B (en) | 2010-06-11 | 2010-06-11 | External medicament for treating dermatophytosis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010101982413A CN101862342B (en) | 2010-06-11 | 2010-06-11 | External medicament for treating dermatophytosis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101862342A CN101862342A (en) | 2010-10-20 |
| CN101862342B true CN101862342B (en) | 2011-08-31 |
Family
ID=42954402
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2010101982413A Active CN101862342B (en) | 2010-06-11 | 2010-06-11 | External medicament for treating dermatophytosis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101862342B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108452045A (en) * | 2018-06-19 | 2018-08-28 | 何永勋 | A kind of composition of medicine for treating athlete's foot |
-
2010
- 2010-06-11 CN CN2010101982413A patent/CN101862342B/en active Active
Non-Patent Citations (1)
| Title |
|---|
| 武德珍等.肤净霜的制备及临床应用.《海南医学》.2005,第16卷(第6期),第136-137页. * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101862342A (en) | 2010-10-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103656025B (en) | A kind of medical liquor for treating injury | |
| CN101862342B (en) | External medicament for treating dermatophytosis | |
| CN103417572A (en) | External medicine for treating beriberi | |
| CN104288177A (en) | Medicament for treating dermatophytosis | |
| CN102228560B (en) | Medicine for treating chronic pharyngitis | |
| CN101564426B (en) | Medicament for external use for treating onychomycosis | |
| CN105664013A (en) | Raw rhubarb compound external-use pain-relieving and swelling-reducing ointment for traumatic injuries | |
| CN105535328A (en) | Chinese patent medicine for treating cervical erosion | |
| CN102940661A (en) | Medicine for treating parotitis | |
| CN104274581B (en) | A kind of lip pomade treating angular cheilitis and preparation method thereof | |
| CN101185694B (en) | Powder agent medicine for treating infantile thrush | |
| CN101194950B (en) | Powder medicine medicament for treating children's stomatitis | |
| CN105878471A (en) | Medicinal liquor for treating rheumatic bone pain and preparation method of same | |
| CN101474280B (en) | Medicament for treating burn and scald, and preparation method thereof | |
| CN102614454A (en) | Traditional Chinese medicine for treating urticaria | |
| CN104095968A (en) | Traditional Chinese medicine for treating heat-retention-in-lung-channel type acne | |
| CN109700868A (en) | A kind of instant particles as Chinese medicine and preparation method thereof for treating psoriasis | |
| CN105963671A (en) | Traditional Chinese medicine composition for treating infantile ascariasis and preparation method thereof | |
| CN104095959A (en) | Traditional Chinese medicine for treating diffuse interstitial granulomatous lung diseases | |
| CN101194992B (en) | Plaster medicament for treating thrush of baby | |
| CN102940810A (en) | Medicinal preparation for treating urinary calculi | |
| CN106491632A (en) | A kind of pharmaceutical composition for treating asthma | |
| CN106511923A (en) | Tea beverage for curing cold | |
| CN101301461A (en) | Medicament for treating urticaria | |
| CN101204441A (en) | External medicine for herpes zoster |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant |